Menu
Data+ Awards: BI helps Quintiles speed new drugs to market

Data+ Awards: BI helps Quintiles speed new drugs to market

Developing a new drug can cost millions of dollars and require years of research. The quicker a pharmaceutical company gets a product to market, the less time and money it spends on R&D and the faster it can begin to earn a return on its investment.

Technologies that can speed up a drug's trial period and more quickly analyze its odds of success can have a huge impact on the bottom line.

Quintiles knows that firsthand. The $4.8 billion company provides clinical research services to the pharmaceutical industry. Among other things, Quintiles plans and monitors clinical trials, recruits patients for trials and submits materials to regulatory agencies.

For the past four years the Cambridge, Mass.-based company has worked to create an integrated suite of software modules to handle all phases of drug research, development and trials.

Its software platform, Infosario, integrates the data and processes associated with a drug's life cycle and includes a data engine to collect, clean and prepare data for analysis. The data can be combined with clinical research data and information from other sources to provide predictive analysis.

Formally launched in 2010, Infosario uses elements from Oracle Business Intelligence Enterprise Edition, Siebel's CRM system, SAS Analytics, Microsoft SQL Server and Informatica's Master Data Management system, as well as Tibco's Spotfire data discovery and visualization tool. At its core is the Quintiles Data Factory, which contains the data operations and collection tools for extracting and organizing clinical and operational data from other repositories.

An executive at a Quintiles customer, a major pharmaceutical company, notes that the traditional method of planning a drug trial involves examining data from prior trials to develop the best approach. Infosario allows the company to design drug trials more quickly and effectively.

ROI

The Quintiles Infosario system allows researchers to revisit decisions made earlier within the same drug trial. That's a big benefit, says Quintiles CIO Richard Thomas, because "clinical trials take six, seven years, so feedback loops collect a lot of data along the way."

Follow Us

Join the ARN newsletter!

Error: Please check your email address.

Tags applicationssoftwareQuintilesbusiness intelligence

Upcoming

Slideshows

In Pictures: Houston, we have a bug - 9 famous software glitches in space

In Pictures: Houston, we have a bug - 9 famous software glitches in space

There’s never a good time to run into software bugs, but some times are worse than others - like during a mission to space. Spacecraft of all shapes and sizes rely heavily on software to complete their objectives. But those missions can be quickly ended by the simplest of human errors when writing code. The omission of an overbar here or overflow error checking code there can mean the difference between success or failure, not to mention the loss of hundreds of millions of dollars, years of work and, on manned missions, human life. Use the arrows above to read about 9 examples that show that, despite the care with which these systems are built, bugs have occurred in spacecraft software since we started to fling rockets into space - and will, no doubt, continue to crop up.

In Pictures: Houston, we have a bug - 9 famous software glitches in space
IN PICTURES: Windows 10 Sydney launch

IN PICTURES: Windows 10 Sydney launch

Tech lovers and party-goers alike headed down to Mrs Macquarie's Chair to be part of the world-first Windows 10 Launch Party. The night featured a presentation by Microsoft Australia managing director, Pip Marlow, DJs, live demonstrations and digital artistry by Lister.

IN PICTURES: Windows 10 Sydney launch

iasset.com is a channel management ecosystem that automates all major aspects of the entire sales, marketing and service process, including data tracking, integrated learning, knowledge management and product lifecycle management.

Show Comments